Travelers Forecast, price target & analysts
Travelers Target price 2025 - Analyst rating & recommendation
Travelers Classifications & Recommendation:
Travelers Price Target
| Target Price | $287.33 |
| Price | $265.14 |
| Potential | 8.37% |
| Number of Estimates | 18 |
| 18 Analysts have issued a price target Travelers 2026 . The average Travelers target price is $287.33. This is 8.37% higher than the current stock price. The highest price target is $312.00 17.67% , the lowest is $258.00 2.69% . | |
| A rating was issued by 27 analysts: 10 Analysts recommend Travelers to buy, 14 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Travelers stock has an average upside potential 2026 of 8.37% . Most analysts recommend the Travelers stock at Hold. |
Sales and Margin forecast 2025, 2026 & 2027
10 Analysts have issued a sales forecast Travelers 2025 . The average Travelers sales estimate is $45.4b . This is 3.37% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $46.1b 1.87% , the lowest is $44.3b 5.69% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $46.4b | 12.23% |
|---|---|---|
| 2025 | $45.4b | 2.15% |
| 2026 | $48.5b | 6.82% |
| 2027 | $51.9b | 6.87% |
1 Analyst has issued an EBITDA forecast Travelers 2025 . The average Travelers EBITDA estimate is $5.3b . This is 60.73% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $5.3b 60.73% , the lowest is $5.3b 60.73% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $14.3b | 33.28% |
|---|---|---|
| 2025 | $5.3b | 63.02% |
| 2026 | $7.3b | 39.06% |
| 2027 | $7.9b | 8.01% |
EBITDA Margin
| 2024 | 30.74% | 18.75% |
|---|---|---|
| 2025 | 11.62% | 62.20% |
| 2026 | 15.12% | 30.12% |
| 2027 | 15.29% | 1.12% |
10 Travelers Analysts have issued a net profit forecast 2025. The average Travelers net profit estimate is $4.3b . This is 0.55% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $4.6b 7.39% , the lowest is $4.0b 5.77% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $5.0b | 67.09% |
|---|---|---|
| 2025 | $4.3b | 14.13% |
| 2026 | $5.6b | 31.67% |
| 2027 | $6.3b | 12.41% |
Net Margin
| 2024 | 10.69% | 48.88% |
|---|---|---|
| 2025 | 9.38% | 12.23% |
| 2026 | 11.56% | 23.24% |
| 2027 | 12.16% | 5.19% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
10 Analysts have issued a Travelers forecast for earnings per share. The average Travelers EPS is $18.80 . This is 2.34% higher than earnings per share in the financial year 2024. The highest EPS forecast is $20.08 9.31% , the lowest is $17.62 4.08% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $21.47 | 67.87% |
|---|---|---|
| 2025 | $18.80 | 12.44% |
| 2026 | $24.76 | 31.70% |
| 2027 | $27.83 | 12.40% |
P/E ratio
| Current | 14.43 | 5.90% |
|---|---|---|
| 2025 | 14.10 | 2.31% |
| 2026 | 10.71 | 24.04% |
| 2027 | 9.53 | 11.02% |
Based on analysts' sales estimates for 2025, the Travelers stock is valued at an EV/Sales of 1.50 and an P/S ratio of 1.32 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 1.45 | 12.40% |
|---|---|---|
| 2025 | 1.50 | 3.39% |
| 2026 | 1.40 | 6.38% |
| 2027 | 1.31 | 6.43% |
P/S ratio
| Current | 1.28 | 16.27% |
|---|---|---|
| 2025 | 1.32 | 3.49% |
| 2026 | 1.24 | 6.38% |
| 2027 | 1.16 | 6.43% |
Current Travelers Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Keefe, Bruyette & Woods |
Outperform
➜
Outperform
|
Unchanged | May 28 2025 |
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | May 19 2025 |
| Evercore ISI Group |
Outperform
➜
Outperform
|
Unchanged | Apr 17 2025 |
| Keefe, Bruyette & Woods |
Outperform
➜
Outperform
|
Unchanged | Apr 17 2025 |
| Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 17 2025 |
| Jefferies |
Hold
➜
Hold
|
Unchanged | Apr 11 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Apr 11 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Keefe, Bruyette & Woods:
Outperform
➜
Outperform
|
May 28 2025 |
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
May 19 2025 |
|
Unchanged
Evercore ISI Group:
Outperform
➜
Outperform
|
Apr 17 2025 |
|
Unchanged
Keefe, Bruyette & Woods:
Outperform
➜
Outperform
|
Apr 17 2025 |
|
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Apr 17 2025 |
|
Unchanged
Jefferies:
Hold
➜
Hold
|
Apr 11 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Apr 11 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
